Intel Corporation Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Fair Value (Tables)

Fair Value (Tables)

6 Months Ended

Jul. 01, 2017

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis



	July 1, 2017								December 31, 2016
	Fair Value Measured and Recorded at Reporting Date Using								Fair Value Measured and Recorded at Reporting Date Using
(In Millions)	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Assets
Cash equivalents:
Corporate debt	$	—	$	2,645	$	—	$	2,645	$	—	$	498	$	—	$	498
Financial institution instruments ¹	3,020		2,139		—		5,159		1,920		811		—		2,731
Government debt ²	—		466		—		466		—		332		—		332
Reverse repurchase agreements	—		2,335		—		2,335		—		768		—		768
Short-term investments:
Corporate debt	—		1,654		6		1,660		—		1,332		6		1,338
Financial institution instruments ¹	—		1,221		—		1,221		—		1,603		—		1,603
Government debt ²	—		277		—		277		—		284		—		284
Trading assets:
Asset-backed securities	—		22		—		22		—		87		—		87
Corporate debt	—		2,461		—		2,461		—		2,847		—		2,847
Financial institution instruments ¹	92		1,544		—		1,636		36		1,608		—		1,644
Government debt ²	31		6,934		—		6,965		32		3,704		—		3,736
Other current assets:
Derivative assets	—		326		—		326		—		382		—		382
Loans receivable	—		86		—		86		—		326		—		326
Marketable equity securities	5,472		432		—		5,904		6,180		—		—		6,180
Other long-term investments:
Corporate debt	—		1,811		5		1,816		—		1,995		6		2,001
Financial institution instruments ¹	—		1,632		—		1,632		—		1,758		—		1,758
Government debt ²	—		1,033		—		1,033		—		957		—		957
Other long-term assets:
Derivative assets	—		64		9		73		—		31		9		40
Loans receivable	—		525		—		525		—		236		—		236
Total assets measured and recorded at fair value	8,615		27,607		20		36,242		8,168		19,559		21		27,748
Liabilities
Other accrued liabilities:
Derivative liabilities	—		444		—		444		—		371		—		371
Other long-term liabilities:
Derivative liabilities	—		125		12		137		—		179		33		212
Total liabilities measured and recorded at fair value	$	—	$	569	$	12	$	581	$	—	$	550	$	33	$	583

Financial Instruments Not Recorded At Fair Value On Recurring Basis [Table Text Block]

The carrying amounts and fair values of financial instruments not recorded at fair value on a recurring basis at the end of each period were as follows:



	July 1, 2017
(In Millions)	Carrying Amount		Fair Value Measured Using						Fair Value
(In Millions)	Carrying Amount		Level 1		Level 2		Level 3		Fair Value
Grants receivable	$	440	$	—	$	440	$	—	$	440
Loans receivable¹	$	2,465	$	—	$	2,465	$	—	$	2,465
Non-marketable cost method investments	$	2,719	$	—	$	—	$	3,457	$	3,457
Reverse repurchase agreements	$	250	$	—	$	250	$	—	$	250
Short-term debt	$	4,117	$	—	$	4,697	$	—	$	4,697
Long-term debt	$	27,855	$	17,980	$	11,630	$	—	$	29,610


¹	Includes a loan receivable of $2.2 billion due from McAfee and TPG. The fair value of this loan receivable approximates its carrying value and we did not obtain or secure collateral against this obligation. For further information, see "Note 9: Acquisitions and Divestitures."



	December 31, 2016
(In Millions)	Carrying Amount		Fair Value Measured Using						Fair Value
(In Millions)	Carrying Amount		Level 1		Level 2		Level 3		Fair Value
Grants receivable	$	361	$	—	$	362	$	—	$	362
Loans receivable	$	265	$	—	$	265	$	—	$	265
Non-marketable cost method investments	$	3,098	$	—	$	—	$	3,890	$	3,890
Reverse repurchase agreements	$	250	$	—	$	250	$	—	$	250
Short-term debt	$	4,609	$	3,006	$	2,114	$	—	$	5,120
Long-term debt	$	20,649	$	12,171	$	9,786	$	—	$	21,957